UNLOCKING
INNOVATION

Our approved biosimilars

truxima-rituximab-abbs.png

Truxima® Prescribing Information

Truxima® Medication Guide

herzuma-trastuzumab-pkrb.png

Herzuma® Prescribing Information

 

simlandi-adalimumab-ryvk.png

Simlandi® Prescribing Information

Simlandi® Medication Guide

Truxima® and Herzuma® are in collaboration with Celltrion in the US.

Pass-HP..png
Teva is committed to expanding access to life-changing medicines with a growing list of biosimilars.

Our pipeline

Biosimilar to Eylea® (aflibercept)
Biosimilar to Prolia® (denosumab)
Biosimilar to Simponi® (golimumab)
Biosimilar to Stelara® (ustekinumab)
Biosimilar to Xgeva® (denosumab)
Biosimilar to Xolair® (omalizumab)
TEV-56191
TEV-56261
TEV-56284
TEV-56285
TEV-56289
TEV-56295
TEV-56296

 

Explore Teva's biosimilar pipeline
Exploring Biosimilars with Teva Biosimilars

Explore biosimilars

Learn why biosimilars are the new frontier.

Learn more
Teva biosimilars Mission: Making Biosimilars accessible to patients who need them

Our mission

Learn how we're making biosimilars more accessible.

Learn more
Teva Capabilities: Finding new ways to unleash value

Our capabilities

See how we’re unleashing value on many fronts.

Learn more
Teva Biosimilar Expertise: Meet the Leaders of Teva

Our expertise

Meet the vanguards leading the way in the new frontier.

Learn more
Teva Biosimilar Products and Partnerships

Our biosimilars

Discover our innovations in the new frontier.

Learn more